Viewing Study NCT04507061


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-01-25 @ 3:01 PM
Study NCT ID: NCT04507061
Status: COMPLETED
Last Update Posted: 2023-04-04
First Post: 2020-08-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.
Sponsor: Bayer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 18748
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators